Clinical Trial Update: Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety, tolerability, and pharmacokinetics of AZD1152 in patients with relapsed acute myeloid leukemia. The results describe tolera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZD1152 (barasertib)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Myeloid Leukaemia | Phase 1 | Status: COMPLETED